$INO Zydus DNA vaccine coming in hot. Validation for DNA vaccines. Can Inovio surprise us before Zydus does... "Apart from the regimen of three doses, it is also testing a two-dose regimen, the trial for which is also expected to be completed in May, Patel said. If the data is equally good, we will look at it; but currently, we believe the three-dose regimen is more suitable for our vaccine and will give a better immune response and longer antibody response, which we have seen in our data," Patel said. livemint.com/companies/news...
@BrezelStockTrader @t_babur ...but the stinker is, they will be at World Vaccine Congress on the 6th showcasing their PharmaJet needle free delivery. While kim sold junk cellectra's to the DOD and are no shows for their cellectra 3psp. LOL